Results 31 to 40 of about 11,219 (248)

Emerging Drugs for Generalized Myasthenia Gravis

Canadian Journal of Health Technologies, 2022
Horizon Scan reports provide brief summaries of information regarding new and emerging health technologies. These technologies are identified through the CADTH Horizon Scanning Service as topics of potential interest to health care decision-makers in Canada.
Sarah Ndegwa, Monika Mierzwinski-Urban
openaire   +2 more sources

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin [PDF]

, 2017
K
Boczán, Judit, Csiba, László, Dankó, Katalin, Kovács, Edina, Nagy-Vincze, Melinda   +4 more
core   +1 more source

Asymmetric pattern in generalized myasthenia gravis

Medicine, 2018
Abstract Rationale: Myasthenia gravis (MG) is an uncommon autoimmune disease mediated by antibodies that attack the postsynaptic acetylcholine receptors (AchRs) at the neuromuscular junction, causing fluctuating muscle weakness, aggravated with use, and relieved with rest.
de Carvalho, Thiago Pereira, Vianna, Clara Louise, Andrade, Felipe Freitas, Alvarenga, Rafaela Abreu, Sales, Liz de Oliveira Moura, Rodrigues, Rosana Souza, Rosado-de-Castro, Paulo Henrique   +6 more
openaire   +2 more sources

Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation. [PDF]

, 2020
BackgroundCongenital myasthenic syndromes (CMSs) are a group of inherited disorders of neuromuscular transmission that may be presynaptic, synaptic, or postsynaptic.
Anderson, Kendall J, Clark, Leigh Anne, Evans, Jacquelyn M, Guo, Ling T, Knipe, Marguerite, Shelton, G Diane, Sturges, Beverly K, Tsai, Kate L, Vernau, Karen M, Williams, D Colette, Winger, Kathryn, Zwueste, Danielle M   +11 more
core  

Myasthenia gravis [PDF]

, 2007
Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups.
Vern C Juel, Janice M Massey, A Evoli, W Hoch, J McConville, DB Sanders, F Scuderi, A Jaretzki III, LH Phillips 2nd, LH Phillips 2nd, JM Aragones, D Grob, D Grob, PI Andrews, T Santa, T Namba, LH Phillips 2nd, LY Dirr, G Moorthy, DW Mulder, NK Ragge, JF Howard, EV Stålberg, AAEM Quality Assurance Committee, American Association of Electrodiagnostic Medicine, DB Sanders, J Lindstrom, A Vincent, PI Andrews, VA Lennon, DB Sanders, FM Howard Jr, N Cikes, DB Sanders, FE Somnier, AM Yamamoto, A Mygland, Y Chagnac, N Canal, JH Frank, VC Juel, BS McEwen, RM Pascuzzi, TR Johns, C Schneider-Gold, RG Miller, ME Seybold, A Sghirlanzoni, J Palace, U Herrllinger, R Hohlfeld, JT Kissel, RS Tindall, E Ciafaloni, DB Sanders, HW Sollinger, V Chaudhry, E Ciafaloni, MN Meriggioli, D Sanders, S Vernino, MN Meriggioli, NIH Consensus Conference, AF Pinching, PC Dau, C Antozzi, P Gajdos, P Gajdos, AI Qureshi, RB Stricker, P Gajdos, C-S Huang, P Gajdos, E Tan, JB Caress, A Blalock, A Blalock, GI Wolfe, GS Gronseth, VP Perlo, M Rodriguez, DG Mulder, Y Monden, E Beghi, DJ Lanska, F Schumm, A Jaretzki III, A Jaretzki III, A Jaretzki III, GB Bulkley, HJ Oosterhuis, MS Sellman, CE Thomas, KE Osserman, JA Simpson, D Grob   +94 more
core   +3 more sources

Guideline for the management of myasthenic syndromes

Therapeutic Advances in Neurological Disorders, 2023
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of (very) rare chronic diseases.
Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Ulrike Schara-Schmidt, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel   +24 more
doaj   +1 more source

A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report

Respiratory Medicine Case Reports, 2023
Background: Shrinking lung syndrome (SLS) is an uncommon complication of systemic lupus erythematosus (SLE) that has also been seen in other autoimmune diseases and is linked with a high risk of acute or chronic respiratory failure.
Safwat Eldaabossi, Man Alrashdan, Ghada Aljanobi, Noha Warsha, Saber Abo Elhassan, Waheed Mahdi, Abdullah Farouk, Ahmad Taha, Ahmad Qabil, Sameh Maklad, Usama Nabway, Hatem Kenany, Yasser Jaber, Boshra Zaghloul   +13 more
doaj   +1 more source

New treatment options for generalized myasthenia gravis

Neurologijos seminarai
Myasthenia gravis is an autoimmune disease in which autoantibodies against the postsynaptic membrane proteins of the neuromuscular junction disrupt impulse transmission thus causing pathological muscle weakness and fatigue that worsens throughout the day.
Antanas Vaitkus, J. Čiauškaitė, M. Malakauskaitė, M. Baublytė   +3 more
doaj   +3 more sources

Acetylcholine receptor antibody positive generalized Myasthenia gravis in association with Primary Biliary Cirrhosis

Annals of Hepatology, 2010
Primary Biliary Cirrhosis and Myasthenia Gravis are both autoimmune conditions, however, there are only rare case reports of their association. This is a case report of acetylcholine receptor antibody positive generalized myasthenia gravis in a female ...
Heather Taddy, Eric M. Yoshida, Gillian Gibson, Nazira Chatur   +3 more
doaj   +1 more source

Eculizumab improves fatigue in refractory generalized myasthenia gravis [PDF]

, 2019
Purpose: To evaluate the effect of eculizumab on perceived fatigue in patients with anti-acetylcholine receptor antibody-positive, refractory, generalized myasthenia gravis (MG) using the Quality of Life in Neurological Disorders (Neuro-QOL) Fatigue ...
Andersen, Henning, De Bleecker, Jan, Howard, James F, Jr, Mantegazza, Renato, O'Brien, Fanny, Patra, Kaushik, REGAIN Study Group, the, Wang, Jing Jing   +7 more
core   +2 more sources